NCT00572598View on ClinicalTrials.gov

Pilot Study of 18F Fluoropaclitaxel (FPAC)

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Breast Cancer
Interventions
DRUG

4- [F-18] fluoropaclitaxel

4- \[F-18\] fluoropaclitaxel, \<84 micrograms, \<10 mCi, IV followed by PET/CT imaging

Trial Locations (1)

23298

Virginia Commonwealth University, Richmond

All Listed Sponsors
lead

Virginia Commonwealth University

OTHER

NCT00572598 - Pilot Study of 18F Fluoropaclitaxel (FPAC) | Biotech Hunter | Biotech Hunter